Xu Bao

Tianjin Third Central Hospital

Papers

1

Total Citations

24

H-Index

1

About

Xu Bao is a leading colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques for pelvic floor disorders, particularly rectal prolapse. His major contributions center on evaluating the comparative efficacy and safety of laparoscopic versus robotic ventral mesh rectopexy, a critical procedure for restoring pelvic anatomy. In his landmark 2021 meta-analysis, Bao synthesized global evidence to assess whether robotic surgery could supplant laparoscopy as the gold standard, demonstrating comparable outcomes with potential advantages in precision and recovery. This work, cited 24 times, has influenced clinical decision-making and sparked ongoing debate in colorectal surgery. Beyond this, Bao’s research portfolio explores surgical innovation, patient safety, and evidence-based practice, with a commitment to improving surgical quality and long-term patient outcomes. His meta-analysis remains a key reference for surgeons and trainees navigating the evolving landscape of robotic-assisted pelvic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Meta-analysis on current status, efficacy, and safety of laparoscopic and robotic ventral mesh rectopexy for rectal prolapse treatment: can robotic surgery become the gold standard?
24 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Tianjin Third Central Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago